Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections | MicrobiomeTrials← Back to trialsNCT06982105
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-05-20Est. Completion: 2027-06
Enrollment target: 100 participants Locations- Riley Hospital for Children, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
ScabiesAtopic DermatitisSecondary Bacterial Skin Infection
This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasa…
Istanbul, Turkey (Türkiye)Est. completion Mar 2027
Hemodialysis
The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and …
Copenhagen, DenmarkEst. completion Oct 2028
Recruiting
Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus Endocarditis
This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream i…
Blacktown, AustraliaEst. completion Jan 2029